Abstract
Background: Polycystic Ovary Syndrome (PCOS) is one of the most prevalent endocrine illnesses among women of reproductive age. PCOS is linked to several issues, including hypothyroidism and metabolic disorders. Hypothyroidism seems to be associated with insulin resistance and other metabolic factors.
Objective: The present study aimed to evaluate the incidence of hypothyroidism in PCOS patients and compare it with healthy controls. Moreover, the impact of hypothyroidism on metabolic parameters, particularly insulin resistance, in PCOS patients was also examined.
Methods: This study was conducted on 41 women with PCOS and 41 healthy women as controls from March to November, 2018. Participants' demographic information was recorded. Thyroid function tests were compared between the case and control groups. Metabolic parameters were examined between hypothyroid and euthyroid PCOS individuals.
Results: Patients with PCOS displayed a greater incidence of hypothyroidism and a higher level of anti-thyroid peroxidase antibodies compared to the control group. High-density lipoprotein (HDL) cholesterol was substantially higher in hypothyroid PCOS patients than in non-hypothyroid individuals, although no significant changes were observed in other metabolic markers. Hypothyroid PCOS patients and those without hypothyroidism did not differ in insulin resistance. Autoimmunity was not found to be linked to a higher risk of metabolic problems.
Conclusion: As evidenced by the results of this study, PCOS patients had a higher prevalence of subclinical hypothyroidism than healthy subjects. Metabolic indicators, except for HDL, were not different between PCOS patients with and without hypothyroidism.
Keywords: PCOS, hypothyroidism, autoimmunity , insulin resistance, dyslipidemia, body mass index
[1]
Lizneva D, Suturina L, Walker W, Brakta S, Gavrilova-Jordan L, Azziz R. Criteria, prevalence, and phenotypes of polycystic ovary syndrome. Fertil Steril 2016; 106(1): 6-15.
[http://dx.doi.org/10.1016/j.fertnstert.2016.05.003] [PMID: 27233760]
[http://dx.doi.org/10.1016/j.fertnstert.2016.05.003] [PMID: 27233760]
[2]
March WA, Moore VM, Willson KJ, Phillips DI, Norman RJ, Davies MJ. The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum Reprod 2010; 25(2): 544-51.
[http://dx.doi.org/10.1093/humrep/dep399] [PMID: 19910321]
[http://dx.doi.org/10.1093/humrep/dep399] [PMID: 19910321]
[3]
Mehrabian F, Khani B, Kelishadi R, Ghanbari E. The prevalence of polycystic ovary syndrome in Iranian women based on different diagnostic criteria. Endokrynol Pol 2011; 62(3): 238-42.
[PMID: 21717406]
[PMID: 21717406]
[4]
Rashidi H, Ramezani Tehrani F, Bahri Khomami M, Tohidi M, Azizi F. To what extent does the use of the Rotterdam criteria affect the prevalence of polycystic ovary syndrome? A community-based study from the Southwest of Iran. Eur J Obstet Gynecol Reprod Biol 2014; 174: 100-5.
[http://dx.doi.org/10.1016/j.ejogrb.2013.12.018] [PMID: 24411130]
[http://dx.doi.org/10.1016/j.ejogrb.2013.12.018] [PMID: 24411130]
[5]
Moran L, Teede H. Metabolic features of the reproductive phenotypes of polycystic ovary syndrome. Hum Reprod Update 2009; 15(4): 477-88.
[http://dx.doi.org/10.1093/humupd/dmp008] [PMID: 19279045]
[http://dx.doi.org/10.1093/humupd/dmp008] [PMID: 19279045]
[6]
Weerakiet S, Bunnag P, Phakdeekitcharoen B, et al. Prevalence of the metabolic syndrome in Asian women with polycystic ovary syndrome: Using the International Diabetes Federation criteria. Gynecol 2007; 23(3): 153-60.
[http://dx.doi.org/10.1080/09513590701214158]
[http://dx.doi.org/10.1080/09513590701214158]
[7]
Indhavivadhana S, Wongwananuruk T, Rattanachaiyanont M, et al. Prevalence of metabolic syndrome in reproductive-aged polycystic ovary syndrome Thai women. J Med Assoc Thai 2010; 93(6): 653-0.
[8]
Hosseinpanah F, Barzin M, Tehrani FR, Azizi F. The lack of association between polycystic ovary syndrome and metabolic syndrome: Iranian PCOS prevalence study. Clin Endocrinol (Oxf) 2011; 75(5): 692-7.
[http://dx.doi.org/10.1111/j.1365-2265.2011.04113.x] [PMID: 21592169]
[http://dx.doi.org/10.1111/j.1365-2265.2011.04113.x] [PMID: 21592169]
[9]
Enzevaei A, Salehpour S, Tohidi M, Saharkhiz N. Subclinical hypothyroidism and insulin resistance in polycystic ovary syndrome: Is there a relationship? Iran J Reprod Med 2014; 12(7): 481-6.
[PMID: 25114670]
[PMID: 25114670]
[10]
Huang R, Zheng J, Li S, Tao T, Liu W. Subclinical hypothyroidism in patients with polycystic ovary syndrome: Distribution and its association with lipid profiles. Eur J Obstet Gynecol Reprod Biol 2014; 177: 52-6.
[http://dx.doi.org/10.1016/j.ejogrb.2014.04.013] [PMID: 24768234]
[http://dx.doi.org/10.1016/j.ejogrb.2014.04.013] [PMID: 24768234]
[11]
Yu Q, Wang JB. Subclinical hypothyroidism in PCOS: Impact on presentation, insulin resistance, and cardiovascular risk. BioMed Res Int 2016; 2016: 2067087.
[http://dx.doi.org/10.1155/2016/2067087] [PMID: 27478827]
[http://dx.doi.org/10.1155/2016/2067087] [PMID: 27478827]
[12]
Maratou E, Hadjidakis DJ, Kollias A, et al. Studies of insulin resistance in patients with clinical and subclinical hypothyroidism. Eur J Endocrinol 2009; 160(5): 785-90.
[http://dx.doi.org/10.1530/EJE-08-0797] [PMID: 19141606]
[http://dx.doi.org/10.1530/EJE-08-0797] [PMID: 19141606]
[13]
Rochon C, Tauveron I, Dejax C, et al. Response of glucose disposal to hyperinsulinaemia in human hypothyroidism and hyperthyroidism Clinical science (London, England: 1979) 2003; 104(1): 7- 15.
[http://dx.doi.org/10.1042/CS20020154]
[http://dx.doi.org/10.1042/CS20020154]
[14]
Dimitriadis G, Mitrou P, Lambadiari V, et al. Insulin action in adipose tissue and muscle in hypothyroidism. J Clin Endocrinol Metab 2006; 91(12): 4930-7.
[http://dx.doi.org/10.1210/jc.2006-0478] [PMID: 17003097]
[http://dx.doi.org/10.1210/jc.2006-0478] [PMID: 17003097]
[15]
Bicíková M, Hampl R, Hill M, Stanická S, Tallová J, Vondra K. Steroids, sex hormone-binding globulin, homocysteine, selected hormones and markers of lipid and carbohydrate metabolism in patients with severe hypothyroidism and their changes following thyroid hormone supplementation. Clin Chem Lab Med 2003; 41(3): 284-92.
[http://dx.doi.org/10.1515/CCLM.2003.045] [PMID: 12705335]
[http://dx.doi.org/10.1515/CCLM.2003.045] [PMID: 12705335]
[16]
Khan SH, Fazal N, Ijaz A, et al. Insulin resistance and glucose levels in subjects with subclinical hypothyroidism. J Coll Physicians Surg Pak 2017; 27(6): 329-33.
[PMID: 28689519]
[PMID: 28689519]
[17]
Kvetny J, Heldgaard PE, Bladbjerg EM, Gram J. Subclinical hypothyroidism is associated with a low-grade inflammation, increased triglyceride levels and predicts cardiovascular disease in males below 50 years. Clin Endocrinol (Oxf) 2004; 61(2): 232-8.
[http://dx.doi.org/10.1111/j.1365-2265.2004.02088.x] [PMID: 15272919]
[http://dx.doi.org/10.1111/j.1365-2265.2004.02088.x] [PMID: 15272919]
[18]
Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to Polycystic Ovary Syndrome (PCOS). Hum Reprod 2004; 19(1): 41-7.
[http://dx.doi.org/10.1093/humrep/deh098] [PMID: 14688154]
[http://dx.doi.org/10.1093/humrep/deh098] [PMID: 14688154]
[19]
Fatourechi V. Subclinical hypothyroidism: an update for primary care physicians. Mayo Clin Proc 2009; 84(1): 65-71.
[http://dx.doi.org/10.4065/84.1.65] [PMID: 19121255]
[http://dx.doi.org/10.4065/84.1.65] [PMID: 19121255]
[20]
Bonora E, Targher G, Alberiche M, et al. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: Studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care 2000; 23(1): 57-63.
[http://dx.doi.org/10.2337/diacare.23.1.57] [PMID: 10857969]
[http://dx.doi.org/10.2337/diacare.23.1.57] [PMID: 10857969]
[21]
Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28(7): 412-9.
[http://dx.doi.org/10.1007/BF00280883] [PMID: 3899825]
[http://dx.doi.org/10.1007/BF00280883] [PMID: 3899825]
[22]
Esteghamati A, Abbasi M, Rashidi A, et al. Optimal waist circumference cut-offs for the diagnosis of metabolic syndrome in Iranian adults: Results of the third national survey of risk factors of non-communicable diseases (SuRFNCD-2007). Diabet Med 2009; 26(7): 745-6.
[http://dx.doi.org/10.1111/j.1464-5491.2009.02756.x] [PMID: 19573127]
[http://dx.doi.org/10.1111/j.1464-5491.2009.02756.x] [PMID: 19573127]
[23]
Ding X, Yang L, Wang J, et al. Subclinical hypothyroidism in polycystic ovary syndrome: A systematic review and meta-analysis. Front Endocrinol (Lausanne) 2018; 9: 700.
[http://dx.doi.org/10.3389/fendo.2018.00700] [PMID: 30542323]
[http://dx.doi.org/10.3389/fendo.2018.00700] [PMID: 30542323]
[24]
Kachuei M, Jafari F, Kachuei A, Keshteli AH. Prevalence of autoimmune thyroiditis in patients with polycystic ovary syndrome. Arch Gynecol Obstet 2012; 285(3): 853-6.
[http://dx.doi.org/10.1007/s00404-011-2040-5] [PMID: 21866332]
[http://dx.doi.org/10.1007/s00404-011-2040-5] [PMID: 21866332]
[25]
Pei YJ, Wang AM, Zhao Y, et al. Studies of cardiovascular risk factors in polycystic ovary syndrome patients combined with subclinical hypothyroidism. Gynecol Endocrinol 2014; 30(8): 553-6.
[http://dx.doi.org/10.3109/09513590.2013.829443]
[http://dx.doi.org/10.3109/09513590.2013.829443]
[26]
Trakakis E, Pergialiotis V, Hatziagelaki E, Panagopoulos P, Salloum I, Papantoniou N. Subclinical hypothyroidism does not influence the metabolic and hormonal profile of women with PCOS. Horm Mol Biol Clin Investig 2017; 31(3)
[http://dx.doi.org/10.1515/hmbci-2016-0058] [PMID: 28672734]
[http://dx.doi.org/10.1515/hmbci-2016-0058] [PMID: 28672734]
[27]
Pergialiotis V, Konstantopoulos P, Prodromidou A, Florou V, Papantoniou N, Perrea DN. Management of endocrine disease: The impact of subclinical hypothyroidism on anthropometric characteristics, lipid, glucose and hormonal profile of PCOS patients: A systematic review and meta-analysis. Eur J Endocrinol 2017; 176(3): R159-66.
[http://dx.doi.org/10.1530/EJE-16-0611] [PMID: 28007842]
[http://dx.doi.org/10.1530/EJE-16-0611] [PMID: 28007842]
[28]
Ganie MA, Laway BA, Wani TA, et al. Association of subclinical hypothyroidism and phenotype, insulin resistance, and lipid parameters in young women with polycystic ovary syndrome. Fertil Steril 2011; 95(6): 2039-43.
[http://dx.doi.org/10.1016/j.fertnstert.2011.01.149] [PMID: 21333983]
[http://dx.doi.org/10.1016/j.fertnstert.2011.01.149] [PMID: 21333983]
[29]
Benetti-Pinto CL, Berini Piccolo VR, Garmes HM, Teatin Juliato CR. Subclinical hypothyroidism in young women with polycystic ovary syndrome: An analysis of clinical, hormonal, and metabolic parameters. Fertil Steril 2013; 99(2): 588-92.
[http://dx.doi.org/10.1016/j.fertnstert.2012.10.006] [PMID: 23103018]
[http://dx.doi.org/10.1016/j.fertnstert.2012.10.006] [PMID: 23103018]
[30]
Trummer C, Schwetz V, Giuliani A, Obermayer-Pietsch B, Lerchbaum E. Impact of elevated thyroid-stimulating hormone levels in polycystic ovary syndrome. Gynecol Endocrinol 2015; 31(10): 819-23.
[http://dx.doi.org/10.3109/09513590.2015.1062864]
[http://dx.doi.org/10.3109/09513590.2015.1062864]
[31]
Celik C, Abali R, Tasdemir N, et al. Is subclinical hypothyroidism contributing dyslipidemia and insulin resistance in women with polycystic ovary syndrome? Gynecol 2012; 28(8): 615-8.
[http://dx.doi.org/10.3109/09513590.2011.650765]
[http://dx.doi.org/10.3109/09513590.2011.650765]
[32]
Mueller A, Schöfl C, Dittrich R, et al. Thyroid-stimulating hormone is associated with insulin resistance independently of body mass index and age in women with polycystic ovary syndrome. Hum Reprod 2009; 24(11): 2924-30.
[http://dx.doi.org/10.1093/humrep/dep285] [PMID: 19654109]
[http://dx.doi.org/10.1093/humrep/dep285] [PMID: 19654109]
[33]
de Medeiros SF, de Medeiros MAS, Ormond CM, Barbosa JS, Yamamoto MMW. Subclinical hypothyroidism impact on the characteristics of patients with polycystic ovary syndrome. A meta-analysis of observational studies. Gynecol Obstet Invest 2018; 83(2): 105-15.
[http://dx.doi.org/10.1159/000485619] [PMID: 30025406]
[http://dx.doi.org/10.1159/000485619] [PMID: 30025406]
[34]
Xing Y, Chen J, Liu J, Ma H. The impact of subclinical hypothyroidism on patients with polycystic ovary syndrome: A meta-analysis. Horm Metab Res 2021; 53(6): 382-90.
[http://dx.doi.org/10.1055/a-1463-3198] [PMID: 34154029]
[http://dx.doi.org/10.1055/a-1463-3198] [PMID: 34154029]
[35]
Kowalczyk K, Radosz P. Barański K, et al. The influence of treated and untreated subclinical hypothyroidism on metabolic profile in women with polycystic ovary syndrome. Int J Endocrinol 2021; 2021: 8427150.
[http://dx.doi.org/10.1155/2021/8427150] [PMID: 34880913]
[http://dx.doi.org/10.1155/2021/8427150] [PMID: 34880913]
Article Metrics
1